Class 4 Drug Caution in use - SLENYTO 1 MG AND 5MG PROLONGED RELEASE TABLETS

Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets (PILs) that have been packaged in the below batches of products. These were an older version of the PIL which did not include the most up to date safety information

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-slenyto-1-mg-and-5mg-prolonged-release-tablets-distributed-by-flynn-pharma-ltd-el-21-a-slash-29?utm_medium=email&utm_campaign=govuk-notifications&utm_source=918a7eae-bd86-4833-899a-5114d92b0980&utm_content=immediately      

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

Further Information

For more information, medical information queries or replacement PIL enquiries, please contact:

Flynn Pharma Ltd Medical Information Department on 01438 727822, email – medinfo@flynnpharma.com.

For stock control queries, please contact: Flynn Pharma Ltd on 01438 727822

If you have any questions, then please contact your local Service Centre Customer Services team.